# Health In Tech, Inc.: financial statements, quarterly

HIT · Nasdaq · CIK 2019505 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hit.md) · [Financials](/companies/hit/financials.md) · [Filings](/companies/hit/filings.md) · [Insiders](/companies/hit/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hit/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,125](/filings/0001213900-25-041566.md) | [5,002](/filings/0001213900-25-073712.md) | [4,459](/filings/0001213900-25-109379.md) | [4,905 d](/filings/0001213900-26-034211.md) | [8,015](/filings/0001213900-26-056707.md) | [9,314](/filings/0001213900-26-089157.md) | [8,490](/filings/0001213900-25-109379.md) | [7,509 d](/filings/0001213900-26-034211.md) | [8,772](/filings/0001213900-26-056707.md) | [8,057](/filings/0001213900-26-089157.md) |
| Cost of revenue | $k | [990](/filings/0001213900-25-041566.md) | [975](/filings/0001213900-25-073712.md) | [980](/filings/0001213900-25-109379.md) | [1,107 d](/filings/0001213900-26-034211.md) | [2,660](/filings/0001213900-26-056707.md) | [3,004](/filings/0001213900-26-089157.md) | [3,346](/filings/0001213900-25-109379.md) | [3,380 d](/filings/0001213900-26-034211.md) | [4,262](/filings/0001213900-26-056707.md) | [4,134](/filings/0001213900-26-089157.md) |
| Gross profit | $k | [4,135](/filings/0001213900-25-041566.md) | [4,028](/filings/0001213900-25-073712.md) | [3,479](/filings/0001213900-25-109379.md) | [3,797 d](/filings/0001213900-26-034211.md) | [5,355](/filings/0001213900-26-056707.md) | [6,310](/filings/0001213900-26-089157.md) | [5,144](/filings/0001213900-25-109379.md) | [4,129 d](/filings/0001213900-26-034211.md) | [4,509](/filings/0001213900-26-056707.md) | [3,922](/filings/0001213900-26-089157.md) |
| Research and development | $k | [760](/filings/0001213900-25-041566.md) | [702](/filings/0001213900-25-073712.md) | [718](/filings/0001213900-25-109379.md) | [634 d](/filings/0001213900-26-034211.md) | [538](/filings/0001213900-26-056707.md) | [583](/filings/0001213900-26-089157.md) | [236](/filings/0001213900-25-109379.md) | [213 d](/filings/0001213900-26-034211.md) | [920](/filings/0001213900-26-056707.md) | [876](/filings/0001213900-26-089157.md) |
| Interest expense | $k | [165](/filings/0001213900-25-041566.md) | [165](/filings/0001213900-25-073712.md) | [165](/filings/0001213900-25-109379.md) | [0.0 d](/filings/0001213900-26-034211.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [91.2](/filings/0001213900-25-041566.md) | [63.3](/filings/0001213900-25-073712.md) | [30.7](/filings/0001213900-25-109379.md) | [33.4 d](/filings/0001213900-26-034211.md) | [186](/filings/0001213900-26-056707.md) | [203](/filings/0001213900-26-089157.md) | [148](/filings/0001213900-25-109379.md) | [(141) d](/filings/0001213900-26-034211.md) | [(480)](/filings/0001213900-26-056707.md) | [(810)](/filings/0001213900-26-089157.md) |
| Net income | $k | [101](/filings/0001213900-25-109379.md) | [338](/filings/0001213900-25-109379.md) | [376](/filings/0001213900-25-109379.md) | [(144) d](/filings/0001213900-26-034211.md) | [499](/filings/0001213900-26-056707.md) | [631](/filings/0001213900-26-089157.md) | [452](/filings/0001213900-25-109379.md) | [(303) d](/filings/0001213900-26-034211.md) | [(1,588)](/filings/0001213900-26-056707.md) | [(2,511)](/filings/0001213900-26-089157.md) |
| Diluted EPS | $ per share | not reported | [0.01](/filings/0001213900-25-073712.md) | [0.01](/filings/0001213900-25-109379.md) | not reported | [0.01](/filings/0001213900-26-056707.md) | [0.01](/filings/0001213900-26-089157.md) | [0.01](/filings/0001213900-25-109379.md) | not reported | [(0.03)](/filings/0001213900-26-056707.md) | [(0.04)](/filings/0001213900-26-089157.md) |
| Basic EPS | $ per share | not reported | [0.01](/filings/0001213900-25-073712.md) | [0.01](/filings/0001213900-25-109379.md) | not reported | [0.01](/filings/0001213900-26-056707.md) | [0.01](/filings/0001213900-26-089157.md) | [0.01](/filings/0001213900-25-109379.md) | not reported | [(0.03)](/filings/0001213900-26-056707.md) | [(0.04)](/filings/0001213900-26-089157.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [2.4](/filings/0001213900-25-024561.md) | not reported | not reported | not reported | [7.8](/filings/0001213900-26-034211.md) | [7.6](/filings/0001213900-25-041566.md) | [8.1](/filings/0001213900-25-073712.md) | [8.0](/filings/0001213900-25-109379.md) | [7.7](/filings/0001213900-26-089157.md) | [10.3](/filings/0001213900-26-056707.md) | [6.5](/filings/0001213900-26-089157.md) |
| Current assets | $m | not reported | [6.9](/filings/0001213900-25-024561.md) | not reported | not reported | not reported | [10.8](/filings/0001213900-26-034211.md) | [15.6](/filings/0001213900-25-041566.md) | [14.9](/filings/0001213900-25-073712.md) | [15.0](/filings/0001213900-25-109379.md) | [16.2](/filings/0001213900-26-089157.md) | [22.1](/filings/0001213900-26-056707.md) | [21.8](/filings/0001213900-26-089157.md) |
| Total assets | $m | not reported | [11.5](/filings/0001213900-25-024561.md) | not reported | not reported | not reported | [15.8](/filings/0001213900-26-034211.md) | [21.3](/filings/0001213900-25-041566.md) | [22.2](/filings/0001213900-25-073712.md) | [22.8](/filings/0001213900-25-109379.md) | [23.1](/filings/0001213900-26-089157.md) | [29.0](/filings/0001213900-26-056707.md) | [29.6](/filings/0001213900-26-089157.md) |
| Current liabilities | $m | not reported | [4.8](/filings/0001213900-25-024561.md) | not reported | not reported | not reported | [2.1](/filings/0001213900-26-034211.md) | [6.8](/filings/0001213900-25-041566.md) | [5.4](/filings/0001213900-25-073712.md) | [5.2](/filings/0001213900-25-109379.md) | [5.2](/filings/0001213900-26-089157.md) | [7.0](/filings/0001213900-26-056707.md) | [10.0](/filings/0001213900-26-089157.md) |
| Total liabilities | $m | not reported | [5.4](/filings/0001213900-25-024561.md) | not reported | not reported | not reported | [2.6](/filings/0001213900-26-034211.md) | [7.2](/filings/0001213900-25-041566.md) | [5.8](/filings/0001213900-25-073712.md) | [5.6](/filings/0001213900-25-109379.md) | [6.0](/filings/0001213900-26-089157.md) | [7.4](/filings/0001213900-26-056707.md) | [10.0](/filings/0001213900-26-089157.md) |
| Shareholders' equity | $m | [1.4](/filings/0001213900-25-024561.md) | [6.1](/filings/0001213900-26-034211.md) | [6.2](/filings/0001213900-25-109379.md) | [6.5](/filings/0001213900-25-109379.md) | [6.9](/filings/0001213900-25-109379.md) | [13.2](/filings/0001213900-26-056707.md) | [14.2](/filings/0001213900-26-056707.md) | [16.4](/filings/0001213900-25-109379.md) | [17.2](/filings/0001213900-25-109379.md) | [17.1](/filings/0001213900-26-056707.md) | [21.6](/filings/0001213900-26-056707.md) | [19.6](/filings/0001213900-26-089157.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(680)](/filings/0001213900-25-041566.md) | [1,267 d](/filings/0001213900-25-073712.md) | [2,121 d](/filings/0001213900-25-109379.md) | [(531) d](/filings/0001213900-26-034211.md) | [527](/filings/0001213900-26-056707.md) | [1,481 d](/filings/0001213900-26-089157.md) | [674 d](/filings/0001213900-25-109379.md) | [451 d](/filings/0001213900-26-034211.md) | [(3,319)](/filings/0001213900-26-056707.md) | [(2,912) d](/filings/0001213900-26-089157.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.8](/filings/0001213900-25-041566.md) | [51.8](/filings/0001213900-25-073712.md) | [51.8](/filings/0001213900-25-109379.md) | [57.0](/filings/0001213900-26-056707.md) | [55.6](/filings/0001213900-26-089157.md) | [58.8](/filings/0001213900-25-109379.md) | [57.4](/filings/0001213900-26-056707.md) | [62.8](/filings/0001213900-26-089157.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.